Department of Pharmacology, Hiroshima University Graduate School of Biomedical & Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.
Department of Pharmacology, Hiroshima University Graduate School of Biomedical & Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.
Brain Behav Immun. 2015 Oct;49:293-310. doi: 10.1016/j.bbi.2015.06.015. Epub 2015 Jun 24.
Spinal cord astrocytes are critical in the maintenance of neuropathic pain. Connexin 43 (Cx43) expressed on spinal dorsal horn astrocytes modulates synaptic neurotransmission, but its role in nociceptive transduction has yet to be fully elaborated. In mice, Cx43 is mainly expressed in astrocytes, not neurons or microglia, in the spinal dorsal horn. Hind paw mechanical hypersensitivity was observed beginning 3days after partial sciatic nerve ligation (PSNL), but a persistent downregulation of astrocytic Cx43 in ipsilateral lumbar spinal dorsal horn was not observed until 7days post-PSNL, suggesting that Cx43 downregulation mediates the maintenance and not the initiation of nerve injury-induced hypersensitivity. Downregulation of Cx43 expression by intrathecal treatment with Cx43 siRNA also induced mechanical hypersensitivity. Conversely, restoring Cx43 by an adenovirus vector expressing Cx43 (Ad-Cx43) ameliorated PSNL-induced mechanical hypersensitivity. The sensitized state following PSNL is likely maintained by dysfunctional glutamatergic neurotransmission, as Cx43 siRNA-induced mechanical hypersensitivity was attenuated with intrathecal treatment of glutamate receptor antagonists MK801 and CNQX, but not neurokinin-1 receptor antagonist CP96345 or the Ca(2+) channel subunit α2δ1 blocker gabapentin. The source of this dysfunctional glutamatergic neurotransmission is likely decreased clearance of glutamate from the synapse rather than increased glutamate release into the synapse. Astrocytic expression of glutamate transporter GLT-1, but not GLAST, and activity of glutamate transport were markedly decreased in mice intrathecally injected with Cx43-targeting siRNA but not non-targeting siRNA. Glutamate release from spinal synaptosomes prepared from mice treated with either Cx43-targeting siRNA or non-targeting siRNA was unchanged. Intrathecal injection of Ad-Cx43 in PSNL mice restored astrocytic GLT-1 expression. The cytokine tumor necrosis factor (TNF) has been implicated in the induction of central sensitization, particularly through its actions on astrocytes, in the spinal cord following peripheral injury. Intrathecal injection of TNF in naïve mice induced the downregulation of both Cx43 and GLT-1 in spinal dorsal horn, as well as hind paw mechanical hypersensitivity, as observed in PSNL mice. Conversely, intrathecal treatment of PSNL mice with the TNF inhibitor etanercept prevented not only mechanical hypersensitivity but also the downregulation of Cx43 and GLT-1 expression in astrocytes. The current findings indicate that spinal astrocytic Cx43 are essential for the maintenance of neuropathic pain following peripheral nerve injury and suggest modulation of Cx43 as a novel target for developing analgesics for neuropathic pain.
脊髓星形胶质细胞在维持神经病理性疼痛中起着关键作用。脊髓背角星形胶质细胞上表达的连接蛋白 43(Cx43)调节突触神经递质传递,但它在伤害性感受转导中的作用尚未完全阐明。在小鼠中,Cx43 主要在脊髓背角的星形胶质细胞中表达,而不在神经元或小胶质细胞中表达。在部分坐骨神经结扎(PSNL)后 3 天观察到后爪机械性超敏反应,但直到 PSNL 后 7 天才观察到同侧腰椎脊髓背角星形胶质细胞 Cx43 的持续下调,这表明 Cx43 的下调介导了神经损伤诱导的超敏反应的维持,而不是起始。鞘内给予 Cx43 siRNA 治疗也会导致机械性超敏反应,从而下调 Cx43 的表达。相反,通过表达 Cx43 的腺病毒载体(Ad-Cx43)恢复 Cx43 表达可改善 PSNL 引起的机械性超敏反应。PSNL 后的敏化状态可能是由功能失调的谷氨酸能神经传递维持的,因为鞘内给予谷氨酸受体拮抗剂 MK801 和 CNQX 可减轻 Cx43 siRNA 诱导的机械性超敏反应,但神经激肽-1 受体拮抗剂 CP96345 或钙通道亚基α2δ1 阻滞剂加巴喷丁则不能。这种功能失调的谷氨酸能神经传递的来源可能是突触中谷氨酸清除减少,而不是突触中谷氨酸释放增加。鞘内注射靶向 Cx43 的 siRNA 而非非靶向 siRNA 的小鼠中,星形胶质细胞谷氨酸转运体 GLT-1 表达,而非 GLAST,以及谷氨酸转运活性明显降低。用 Cx43 靶向 siRNA 或非靶向 siRNA 处理的小鼠脊髓突触小体中谷氨酸的释放没有改变。在 PSNL 小鼠中鞘内注射 Ad-Cx43 可恢复星形胶质细胞 GLT-1 的表达。细胞因子肿瘤坏死因子(TNF)已被牵涉到外周损伤后脊髓中中枢敏化的诱导中,特别是通过其对星形胶质细胞的作用。鞘内注射 TNF 可诱导 naïve 小鼠脊髓背角中 Cx43 和 GLT-1 的下调,以及后爪机械性超敏反应,这与 PSNL 小鼠相似。相反,鞘内给予 TNF 抑制剂依那西普可预防 PSNL 小鼠不仅机械性超敏反应,而且还可预防星形胶质细胞中 Cx43 和 GLT-1 表达的下调。目前的发现表明,脊髓星形胶质细胞 Cx43 是外周神经损伤后神经病理性疼痛维持所必需的,并表明调节 Cx43 可能是开发神经病理性疼痛治疗药物的新靶点。